Cantourage Group SEXTER:HIGH +0.97%29 Gross Margin % is 0.00% as of Jun. 2025. GuruFocus rates XTER:HIGH with a GF Score™ of 29/100. The stock has 4 warning signs investors should review. Among 935 Drug Manufacturers companies, Cantourage Group SE ranks worse than 78.5% on this metric.
The historical rank and industry rank for Cantourage Group SE's Gross Margin % or its related term are showing as below:
XTER:HIGH'
s Gross Margin % Range Over the Past 10 Years
Min: 19.06 Med: 31.46 Max: 35.14
Current: 31.46
During the past 5 years, the highestGross Margin % of Cantourage Group SE was 35.14%. The lowest was 19.06%. And the median was 31.46%.
XTER:HIGH's Gross Margin % is ranked worse than 78.5% of 935
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs XTER:HIGH: 31.46
Cantourage Group SE had a gross margin of N/A% for the quarter that ended in Jun. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Cantourage Group SE was 0.00% per year.
Cantourage Group SE (XTER:HIGH) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Cantourage Group SE had a gross margin of N/A% for the quarter that ended in Jun. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Cantourage Group SE Gross Margin % Related Terms
Cantourage Group SE Gross Margin % Historical Data
* Premium members only.
The historical data trend for Cantourage Group SE's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:HIGH vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cantourage Group SE Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Cantourage Group SE's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Cantourage Group SE (XTER:HIGH) has a Gross Margin % of 0.00% as of Jun. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Cantourage Group SE and its competitors. Over the past decade, Cantourage Group SE's Gross Margin % has ranged from 19.06 to 35.14. According to the industry distribution chart, Cantourage Group SE ranks #734 out of 935 companies in the Drug Manufacturers industry, placing it in the top 78.5%.
Is Cantourage Group SE's Gross Margin % too high?
Cantourage Group SE's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 19.06 to a high of 35.14. Based on the distribution chart, Cantourage Group SE ranks #734 out of 935 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cantourage Group SE has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cantourage Group SE ranks #734 out of 935 companies for Gross Margin %. This places Cantourage Group SE in the lower half of its industry. The industry median Gross Margin % is 48.54. Historically, Cantourage Group SE's own Gross Margin % has ranged from 19.06 to 35.14 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Cantourage Group SE and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantourage Group SE's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (XTER:HIGH) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Cantourage Group SE's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Cantourage Group SE (XTER:HIGH), the current Gross Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
29GF Score
Get the complete analysis for XTER:HIGH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:HIGH has been successfully added to your 
